Table of Content

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Spine Biologics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product
6.1 Spinal Allografts
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Machined Bones Allograft
6.1.2.2 Demineralized Bone Matrix
6.1.3 Market Forecast
6.2 Bone Graft Substitutes
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Bone Morphogenetic Proteins
6.2.2.2 Synthetic Bone Grafts
6.2.3 Market Forecast
6.3 Cell Based Matrix
6.3.1 Market Trends
6.3.2 Market Forecast

7 Market Breakup by Surgery Type
7.1 Open Spine Surgery
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Minimally Invasive Spine Surgery
7.2.1 Market Trends
7.2.2 Market Forecast

8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ambulatory Care Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Spinal Surgery Centers
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Orthopedic Clinics
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast

9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast

10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Arthrex Inc
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 SWOT Analysis
14.3.2 Alphatec Holdings Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Exactech Inc
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Johnson & Johnson
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Medtronic plc
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 NuVasive Inc
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Orthofix Medical Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Stryker Corporation
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Wright Medical Group N.V.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 SWOT Analysis
14.3.10 Zimmer Biomet
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Spine Biologics Market: Major Drivers and Challenges
Figure 2: Global: Spine Biologics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Spine Biologics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Spine Biologics Market: Breakup by Product (in %), 2021
Figure 5: Global: Spine Biologics Market: Breakup by Surgery Type (in %), 2021
Figure 6: Global: Spine Biologics Market: Breakup by End User (in %), 2021
Figure 7: Global: Spine Biologics Market: Breakup by Region (in %), 2021
Figure 8: Global: Spine Biologics (Spinal Allografts) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Spine Biologics (Spinal Allografts) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Spine Biologics (Bone Graft Substitutes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Spine Biologics (Bone Graft Substitutes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Spine Biologics (Cell Based Matrix) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Spine Biologics (Cell Based Matrix) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Spine Biologics (Open Spine Surgery) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Spine Biologics (Open Spine Surgery) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Spine Biologics (Minimally Invasive Spine Surgery) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Spine Biologics (Minimally Invasive Spine Surgery) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Spine Biologics (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Spine Biologics (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Spine Biologics (Ambulatory Care Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Spine Biologics (Ambulatory Care Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Spine Biologics (Spinal Surgery Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Spine Biologics (Spinal Surgery Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Spine Biologics (Orthopedic Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Spine Biologics (Orthopedic Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Spine Biologics (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Spine Biologics (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: North America: Spine Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: North America: Spine Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: United States: Spine Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: United States: Spine Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Canada: Spine Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Canada: Spine Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Asia-Pacific: Spine Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Asia-Pacific: Spine Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: China: Spine Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: China: Spine Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Japan: Spine Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Japan: Spine Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: India: Spine Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: India: Spine Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: South Korea: Spine Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: South Korea: Spine Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Australia: Spine Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Australia: Spine Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Indonesia: Spine Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Indonesia: Spine Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Others: Spine Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Others: Spine Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Europe: Spine Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Europe: Spine Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Germany: Spine Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Germany: Spine Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: France: Spine Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: France: Spine Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: United Kingdom: Spine Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: United Kingdom: Spine Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Italy: Spine Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Italy: Spine Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Spain: Spine Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Spain: Spine Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Russia: Spine Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Russia: Spine Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Others: Spine Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Others: Spine Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Latin America: Spine Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Latin America: Spine Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Brazil: Spine Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Brazil: Spine Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Mexico: Spine Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Mexico: Spine Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Others: Spine Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Others: Spine Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Middle East and Africa: Spine Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Middle East and Africa: Spine Biologics Market: Breakup by Country (in %), 2021
Figure 76: Middle East and Africa: Spine Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Global: Spine Biologics Industry: SWOT Analysis
Figure 78: Global: Spine Biologics Industry: Value Chain Analysis
Figure 79: Global: Spine Biologics Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Spine Biologics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Spine Biologics Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Spine Biologics Market Forecast: Breakup by Surgery Type (in Million US$), 2022-2027
Table 4: Global: Spine Biologics Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Spine Biologics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Spine Biologics Market: Competitive Structure
Table 7: Global: Spine Biologics Market: Key Players